Graves disease in childhood: A review of the options for diagnosis and treatment

Pediatric Drugs

Volumn 5, Issue 2, 2003, Pages 95-102

  Dötsch, Jörg ^a,b   Rascher, Wolfgang ^a   Dörr, Helmuth G ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; CARBIMAZOLE; PROPRANOLOL; PROPYLTHIOURACIL; THIAMAZOLE;

AGRANULOCYTOSIS; ARTHRITIS; BRADYCARDIA; BRONCHOSPASM; DISEASE ASSOCIATION; DISEASE SEVERITY; DOSE RESPONSE; EYE DISEASE; GOITER; GRAVES DISEASE; HEPATITIS; HUMAN; HYPERTHYROIDISM; HYPOPARATHYROIDISM; LARYNGEAL NERVE; LEUKOPENIA; LONG TERM CARE; LUPUS ERYTHEMATOSUS; LYMPHADENOPATHY; MORTALITY; NAUSEA; NERVE PARALYSIS; PRIORITY JOURNAL; RASH; REMISSION; REVIEW; RISK FACTOR; SURGICAL TECHNIQUE; TASTE DISORDER; THYROID CARCINOMA; THYROID GLAND; THYROIDECTOMY; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0037272630     PISSN: 11745878     EISSN: None     Source Type: Journal    
DOI: 10.2165/00128072-200305020-00003     Document Type: Review

References (54)

1. Muzsnai A, Beregszaszi M, Blatnieczky L, et al. Treatment of hyperthyroidism in children and adolescents. Horm Res 1994; 41: 142-6
2. Perrild H, Grüters-Kieslich A, Feldt-Rasmussen U, et al. Diagnosis and treatment of thyrotoxicosis in childhood: a European questionnaire study. Eur J Endocrinol 1994; 131: 467-73
3. Grüters A. Treatment of Graves' disease in children and adolescents. Horm Res 1998; 49: 255-7
4. Dallas JS, Foley Jr TP. Hyperthyroidism. In: Lifshitz F, editor. Pediatric endocrinology. New York: Marcel Dekker, 1996: 401-14
5. Dötsch J, Siebler T, Hauffa BP, et al. Diagnosis and management of juvenile hyperthyroidism in Germany: a retrospective multicenter study. J Pediatr Endocrinol Metab 2000; 13: 879-85
6. De Bruin TW, Braverman LE, Brown RS. Heterogenity of TSH receptor-binding anti-bodies in Hashimoto's thyroiditis and Graves' disease. Am J Med Sci 1990; 299: 291-7
7. Ilicki A, Gamstedt A, Karlsson FA. Hyperthyroid Graves' disease without detectable thyrotropin receptor antibodies. J Clin Endocrinol Metab 1992; 74: 1090-4
8. Lippe BM, Landaw EM, Kaplan SA. Hyperthyroidism in children treated with long term medical therapy: twenty-five percent remission every two years. J Clin Endocrinol Metab 1987; 64: 1241-5
9. Glaser NS, Styne DM. Predictors of early remission of hyperthyroidism in children. J Clin Endocrinol Metab 1997; 82: 1719-26
10. Franklyn JA. The management of hyperthyroidism. N Engl J Med 1994; 330: 1731-8
11. Rivkees SA, Sklar C, Freemark M. The management of Graves' disease in children, with special emphasis on radioiodine treatment. J Clin Endocrinol Metab 1998; 83: 3767-76
12. Shulman DI, Muhar I, Jorgensen EV, et al. Autoimmune hyperthyroidism in prepubertal children and adolescents: comparison of clinical and biochemical features at diagnosis and responses to medical therapy. Thyroid 1997; 7: 755-60
13. Bergman P, Auldist AW, Cameron F. Review of the outcome of management of Graves' disease in children and adolescents. J Paediatr Child Health 2001; 37: 176-82
14. Hashizume K, Ichikawa K, Sakurai A, et al. Administration of thyroxine in treated Graves' disease: effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism. N Engl J Med 1991; 324: 947-53
15. Raber W, Kmen E, Waldhausl W, et al. Medical therapy of Graves' disease: effect on remission rates of methimazole alone and in combination with triiodothyronine. Eur J Endocrinol 2000; 142: 117-24
16. Vitti P, Rago T, Chiovato L, et al. Clinical features of patients with Graves' disease undergoing remission after antithyroid drug treatment. Thyroid 1997; 7: 369-75
17. Bouma DJ, Kammer H, Greer MA. Follow-up comparison of short-term versus 1-year antithyroid drug therapy for the thyrotoxicosis of Graves' disease. J Clin Endocrinol Metab 1982; 55: 1138-42
18. Cooper DS. Antithyroid drugs. N Engl J Med 1992; 311: 1353-62
19. Wartofsky L. Has the use of antithyroid drugs for Graves' disease become obsolete. Thyroid 1993; 3: 335-44
20. Wilson R, Buchanan L, Fraser WD, et al. Evidence for carbimazole as an antioxidant. Autoimmunity 1998; 27: 149-53
21. Segni M, Gorman CA. The aftermath of childhood hyperthyroidism. J Pediatr Endocrinol Metab 2001; 14 Suppl. 5: 1277-82
22. Friend DG. Iodide therapy [letter]. N Engl J Med 1960; 1358: 1358
23. Levy M. Propylthiouracil hepatotoxicity: a review and case presentation. Clin Pediatr (Phila) 1993; 32: 25-9
24. Atkins P, Cohen SB, Phillips BJ. Drug therapy for hyperthyroidism in pregnancy: safety issues for mother and fetus. Drug Saf 2000; 23: 229-44
25. Mandel SJ, Brent GA, Larsen PR. Review of antithyroid drug use during pregnancy and report of a case of aplasia cutis. Thyroid 1994; 4: 129-33
26. Johnsson E, Larsson G, Ljunggren M. Severe malformations in infants born to hyperthyroid woman on methimazole [letter]. Lancet 1997; 350: 1520
27. Davies TF, Roti E, Braveman LE, et al. Thyroid controversy-stimulating antibodies. J Clin Endocrinol Metab 1998; 83: 3777-85
28. Allahabadia A, Daykin J, Holder RL, et al. Age and gender predict the outcome of treatment for Graves' hyperthyroidism. J Clin Endocrinol Metab 2000; 85: 1038-42
29. Karlsson FA, Tuvemo T, Akerström G. Childhood Graves' disease-remission rate and risk factors. J Clin Endocrinol Metab 1998; 83: 1398-9
30. Dobyns BM, Sheline GE, Workman JB, et al. Malignant and benign neoplasms of the thyroid in patients treated for hyperthyroidism: a report of the cooperative thyrotoxicosis therapy follow-up study. J Clin Endocrinol Metab 1974; 38: 976-98
31. Cheetham TD, Wraight P, Hughes IA, et al. Radioiodine treatment of Graves' disease in young people. Horm Res 1998; 49: 258-62
32. Witte J, Goretzki P, Röher HD. Surgery for Graves disease in childhood and adolescence. Exp Clin Endocrinol Diabetes 1997; 105: 58-60
33. Clark JD, Gelfand MJ, Elgazzar AH. Iodine-131 therapy of hyperthyroidism in pediatric patients. J Nucl Med 1995; 36: 442-5
34. Rudberg C, Johansson H, Akerström G, et al. Graves' disease in children and adolescents: late results of surgical treatment. Eur J Endocrinol 1996; 134: 710-5
35. Ward L, Huot C, Lambert R, et al. Outcome of pediatric Graves' disease after treatment with antithyroid medication and radioiodine. Clin Invest Med 1999; 22: 132-9
36. Zimmerman D, Lteif AN. Thyrotoxicosis in children. Endocrinol Metab Clin North Am 1998; 27: 109-26
37. Wiersinga WM. Preventing Graves' ophthalmopathy. N Engl J Med 1998; 338: 121-2
38. Buckingham BA, Costin G, Roe TF, et al. Hyperthyroidism in children: a reevaluation of treatment. Am J Dis Child 1981; 135: 112-7
39. Miccoli P, Vitti P, Rago T, et al. Surgical treatment of Graves' disease: subtotal or total thyroidectomy. Surgery 1996; 120: 1020-4
40. Witte J, Goretzki PE, Dotzenrath C, et al. Surgery for Graves' disease: total versus subtotal thyroidectomy-results of a prospective randomized trial. World J Surg 2000; 24: 1303-11
41. Alsanea O, Clark OH. Treatment of Graves' disease: the advantages of surgery. Endocrinol Metab Clin North Am 2000; 29: 321-37
42. Graham GD, Burman KD. Radioiodine treatment of Graves' disease: an assessment of its potential risks. Ann Intern Med 1986; 105: 900-5
43. Levy WJ, Schumacher OP, Gupta M. Treatment of childhood Graves' disease: a review with emphasis on radioiodine treatment. Cleve Clin J Med 1988; 55: 373-82
44. Vitti P, Martino E, Aghini-Lombardi F, et al. Thyroid volume measurement by ultrasound in children as a tool for the assessment of mild iodine deficiency. J Clin Endocrinol Metab 1994; 79: 600-3
45. Peters H, Fischer C, Bogner U, et al. Radioiodine therapy of Graves' hyperthyroidism: standard vs calculated 131iodine activity: results from a prospective, randomized, multicentre study. Eur J Clin Invest 1995; 25: 186-93
46. Aizawa Y, Yoshida K, Kaise N, et al. The development of transient hypothyroidism after iodine-131 treatment in hyperthyroid patients with Graves' disease: prevalence, mechanism and prognosis. Clin Endocrinol (Oxf) 1997; 46: 1-5
47. Cooper DS. Treatment of thyrotoxicosis. In: Braverman LE, Utiger RD, editors. The thyroid: a fundamental and clinical text. 6th ed. Philadelphia (PA): Lippincott, 1991: 887-916
48. Robbins J, Schneider AB. Thyroid cancer following exposure to radioactive iodine. Rev Endocr Metab Disord 2000; 1: 197-203
49. Beierwaltes WH. The treatment of hyperthyroidism with iodine-131. Semin Nucl Med 1978; 8: 95-103
50. Bondeson AG, Bondeson L, Thompson NW. Hyperparathyroidism after treatment with radioactive iodine: not only a coincidence. Surgery 1989; 106: 1025-7
51. Fjalling M, Dackenberg A, Hedman I, et al. An evaluation of the risk of developing hyperparathyroidism after 131I treatment for thyrotoxicosis. Acta Chir Scand 1983; 149: 681-6
52. Benua RS, Becker DV, Hurley JR. Thyroid storm. Curr Ther Endocrinol Metab 1994; 5: 75-7
53. Bartalena L, Marcocci C, Bogazzi F, et al. Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy. N Engl J Med 1998; 338: 73-8
54. Chan W, Wong GW, Fan DS, et al. Ophthalmopathy in childhood Graves' disease. Br J Ophthalmol 2002; 86: 740-2